4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000068
Director sold 150,000 shares at $5.92 ($888,540)
- Director acquired 150,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KRIEGSMAN STEVEN A Director | 2014-01-23 | Option exercise | +100,000 | $1.18 | $118,000 | 105,000 | D |
| KRIEGSMAN STEVEN A Director | 2014-01-23 | Option exercise | +50,000 | $2.31 | $115,500 | 155,000 | D |
| KRIEGSMAN STEVEN A Director | 2014-01-23 | Sale | −150,000 | $5.92 | $888,540 | 5,000 | D |
| Derivatives | |||||||
| KRIEGSMAN STEVEN A Director | 2014-01-23 | Option exercise · Stock Option (right to buy) | −100,000 | 0 | D | ||
| KRIEGSMAN STEVEN A Director | 2014-01-23 | Option exercise · Stock Option (right to buy) | −50,000 | 0 | D | ||
| Open-market sales · 150,000 sh · avg $5.92 · $888,540 | |||||||
Loading xslF345X03/primary_doc.xml…